Literature DB >> 24238695

Cutaneous lupus erythematosus: diagnosis and treatment.

L G Okon1, V P Werth.   

Abstract

Cutaneous lupus erythematosus (CLE) encompasses a wide range of dermatologic manifestations, which may or may not be associated with the development of systemic disease. Cutaneous lupus is divided into several sub-types, including acute CLE (ACLE), sub-acute CLE (SCLE) and chronic CLE (CCLE). CCLE includes discoid lupus erythematosus (DLE), LE profundus (LEP), chilblain cutaneous lupus and lupus tumidus. The diagnosis of these diseases requires proper classification of the sub-type, through a combination of physical examination, laboratory studies, histology, antibody serology and occasionally direct immunofluorescence, while ensuring to exclude systemic disease. The treatment of cutaneous lupus consists of patient education on proper sun protection along with appropriate topical and systemic agents. Systemic agents are indicated in cases of widespread, scarring or treatment-refractory disease. In this chapter, we discuss issues in classification and diagnosis of the various sub-types of CLE, as well as provide an update on therapeutic management. Published by Elsevier Ltd.

Entities:  

Keywords:  Acute cutaneous lupus erythematosus; Chronic cutaneous lupus erythematosus; Cutaneous lupus erythematosus; Diagnosis; Discoid lupus erythematosus; Lupus erythematosus profundus; Lupus erythematosus tumidus; Sub-acute cutaneous lupus erythematosus; Systemic lupus erythematosus; Treatment

Mesh:

Substances:

Year:  2013        PMID: 24238695      PMCID: PMC3927537          DOI: 10.1016/j.berh.2013.07.008

Source DB:  PubMed          Journal:  Best Pract Res Clin Rheumatol        ISSN: 1521-6942            Impact factor:   4.098


  79 in total

1.  Subacute cutaneous lupus erythematosus with pityriasis-like cutaneous manifestations.

Authors:  M Caproni; C Cardinali; E Salvatore; P Fabbri
Journal:  Int J Dermatol       Date:  2001-01       Impact factor: 2.736

2.  Phototesting in lupus erythematosus: a 15-year experience.

Authors:  A Kuhn; M Sonntag; D Richter-Hintz; C Oslislo; M Megahed; T Ruzicka; P Lehmann
Journal:  J Am Acad Dermatol       Date:  2001-07       Impact factor: 11.527

Review 3.  Cutaneous lupus erythematosus.

Authors:  D P McCauliffe
Journal:  Semin Cutan Med Surg       Date:  2001-03

4.  Successful treatment of generalized discoid skin lesions with azathioprine.

Authors:  S Shehade
Journal:  Arch Dermatol       Date:  1986-04

5.  Distinctive cutaneous subsets in the spectrum of lupus erythematosus.

Authors:  J N Gilliam; R D Sontheimer
Journal:  J Am Acad Dermatol       Date:  1981-04       Impact factor: 11.527

6.  Subacute cutaneous lupus erythematosus and its association with drugs: a population-based matched case-control study of 234 patients in Sweden.

Authors:  C M Grönhagen; C M Fored; M Linder; F Granath; F Nyberg
Journal:  Br J Dermatol       Date:  2012-07-05       Impact factor: 9.302

Review 7.  Malignancy concerns of topical calcineurin inhibitors for atopic dermatitis: facts and controversies.

Authors:  Diamant Thaçi; Rebekka Salgo
Journal:  Clin Dermatol       Date:  2010 Jan-Feb       Impact factor: 3.541

8.  Cutaneous lupus erythematosus: first multicenter database analysis of 1002 patients from the European Society of Cutaneous Lupus Erythematosus (EUSCLE).

Authors:  Cyrus Biazar; Johanna Sigges; Nikolaos Patsinakidis; Vincent Ruland; Susanne Amler; Gisela Bonsmann; Annegret Kuhn
Journal:  Autoimmun Rev       Date:  2012-09-18       Impact factor: 9.754

Review 9.  Cutaneous lupus erythematosus: diagnosis and management.

Authors:  Paolo Fabbri; Carla Cardinali; Barbara Giomi; Marzia Caproni
Journal:  Am J Clin Dermatol       Date:  2003       Impact factor: 7.403

10.  Effects of belimumab, a B lymphocyte stimulator-specific inhibitor, on disease activity across multiple organ domains in patients with systemic lupus erythematosus: combined results from two phase III trials.

Authors:  Susan Manzi; Jorge Sánchez-Guerrero; Joan T Merrill; Richard Furie; Dafna Gladman; Sandra V Navarra; Ellen M Ginzler; David P D'Cruz; Andrea Doria; Simon Cooper; Z John Zhong; Douglas Hough; William Freimuth; Michelle A Petri
Journal:  Ann Rheum Dis       Date:  2012-05-01       Impact factor: 19.103

View more
  56 in total

1.  Treatment of lupus erythematosus of the eyelids with pulsed dye laser.

Authors:  Susana Brás; Borja Gonzalez; Gonzalo Segurado-Miravalles; Pablo Boixeda
Journal:  Lasers Med Sci       Date:  2016-12-21       Impact factor: 3.161

Review 2.  Therapeutic options for cutaneous lupus erythematosus: recent advances and future prospects.

Authors:  Joshua Chang; Victoria P Werth
Journal:  Expert Rev Clin Immunol       Date:  2016-06-01       Impact factor: 4.473

3.  Fatigue in systemic lupus erythematosus and other autoimmune skin diseases.

Authors:  M Tarazi; R G Gaffney; D Pearson; C J Kushner; V P Werth
Journal:  Br J Dermatol       Date:  2018-11-22       Impact factor: 9.302

Review 4.  Pathogenesis of Skin Injury of Systemic Lupus Erythematosus.

Authors:  Guo-Min Deng
Journal:  Curr Rheumatol Rep       Date:  2018-02-21       Impact factor: 4.592

5.  The use of SLICC and ACR criteria to correctly label patients with cutaneous lupus and systemic lupus erythematosus.

Authors:  Aoibheann Flynn; Eimear Gilhooley; Finbar O'Shea; Bairbre Wynne
Journal:  Clin Rheumatol       Date:  2018-02-01       Impact factor: 2.980

Review 6.  Cutaneous Lupus Erythematosus: Progress and Challenges.

Authors:  Amy J Petty; Lauren Floyd; Christopher Henderson; Matilda W Nicholas
Journal:  Curr Allergy Asthma Rep       Date:  2020-04-04       Impact factor: 4.806

Review 7.  Practice and Educational Gaps in Lupus, Dermatomyositis, and Morphea.

Authors:  Nicole M Fett; David Fiorentino; Victoria P Werth
Journal:  Dermatol Clin       Date:  2016-07       Impact factor: 3.478

Review 8.  Insights from Mendelian Interferonopathies: Comparison of CANDLE, SAVI with AGS, Monogenic Lupus.

Authors:  Hanna Kim; Gina A Montealegre Sanchez; Raphaela Goldbach-Mansky
Journal:  J Mol Med (Berl)       Date:  2016-09-27       Impact factor: 4.599

Review 9.  Novel role of long non-coding RNAs in autoimmune cutaneous disease.

Authors:  Anastasiya Muntyanu; Michelle Le; Zainab Ridha; Elizabeth O'Brien; Ivan V Litvinov; Philippe Lefrançois; Elena Netchiporouk
Journal:  J Cell Commun Signal       Date:  2021-08-03       Impact factor: 5.782

10.  Risk of systemic autoimmune diseases in gastric disease patients with proton pump inhibitor use: a nationwide cohort study in Taiwan.

Authors:  Hung-Yi Chen; Jiun-Jie Lin; Bo Yang; Mei-Chen Lin
Journal:  Clin Rheumatol       Date:  2020-03-09       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.